You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
AstraZeneca
Moodys
Johnson and Johnson
Baxter

Last Updated: May 10, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MICONAZOLE NITRATE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Miconazole Nitrate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00498680 Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i Unknown status Rambam Health Care Campus Phase 4 2007-03-01 A prospective, randomized, 3-arm parallel trial on 45 males with ED that were never exposed to PDE5i therapy (naïve patients) will be enrolled.In each group, every patient will receive three treatment regimes (Viagra®50mg & Levitra®10mg, Viagra®100mg, Levitra®20mg), in different sequences of administration in such a manner that eventually each patient will receive all regimes in a double- blinded fasion.Safety will be evaluated at pre- screening by measuring hourly vital signs (blood pressure, heart rate)for 4 consecutive hours after taking half-dose combination. Any decrease in blood pressure of 20 mmhg below baseline will exclude the subject from the study. Effcacy will be evaluated by questionnaires (IIEF, Quality of erection questionnaire, grade of erection scale, Sear, QVS and Sexual Encounter Profiles for each sexual event). Non-parametric statistical analysis of the collected data Comparing the 3 groups will be performed.
NCT00702507 Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants Completed GlaxoSmithKline Phase 4 2007-05-01 The purpose of this study is to determine whether repeated use of 0.25% miconazole nitrate ointment in newborns and infants with a yeast infection in the diaper area causes the yeast to become resistant to the drug.
NCT00702507 Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants Completed Stiefel, a GSK Company Phase 4 2007-05-01 The purpose of this study is to determine whether repeated use of 0.25% miconazole nitrate ointment in newborns and infants with a yeast infection in the diaper area causes the yeast to become resistant to the drug.
NCT01731574 DDI Potential: Dapivirine Vaginal Ring and Miconazole Nitrate Completed International Partnership for Microbicides, Inc. Phase 1 2012-12-01 This trial will investigate the potential drug-drug interaction between dapivirine vaginal Ring-004 and vaginally administered miconazole nitrate, and will evaluate the safety of co-administration of the dapivirine vaginal ring and miconazole nitrate in healthy, HIV-negative women.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Miconazole Nitrate

Condition Name

Condition Name for Miconazole Nitrate
Intervention Trials
Vulvovaginal Candidiasis 1
Tinea Cruris 1
Impotence 1
HIV 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Miconazole Nitrate
Intervention Trials
Candidiasis, Vulvovaginal 1
Candidiasis 1
Tinea 1
Drug-Related Side Effects and Adverse Reactions 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Miconazole Nitrate

Trials by Country

Trials by Country for Miconazole Nitrate
Location Trials
United States 5
Brazil 1
Ecuador 1
Belgium 1
Dominican Republic 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Miconazole Nitrate
Location Trials
Missouri 1
Texas 1
Georgia 1
Florida 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Miconazole Nitrate

Clinical Trial Phase

Clinical Trial Phase for Miconazole Nitrate
Clinical Trial Phase Trials
Phase 4 2
Phase 2 2
Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Miconazole Nitrate
Clinical Trial Phase Trials
Completed 4
Unknown status 1
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Miconazole Nitrate

Sponsor Name

Sponsor Name for Miconazole Nitrate
Sponsor Trials
Biolab Sanus Farmaceutica 1
Population Council 1
International Partnership for Microbicides, Inc. 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Miconazole Nitrate
Sponsor Trials
Industry 4
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Merck
Express Scripts
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.